Skip to main content
INFU logo

InfuSystem Holdings, Inc.

INFUNYSEAMERICANHealthcareMedical Devices

$14.13Today:- (-)1Y +40.56%

As of Oct 27, 2026 close

Market cap
$295.60M
P/E (TTM)
34.60
Forward P/E
20.59
Dividend yield
-
52-week range
$7.29$14.27
Volume (live)
-
Avg. volume (3M)
132.31K

InfuSystem Holdings (INFU) Income Statement

InfuSystem Holdings reported revenue of $143.44M in fiscal 2025 (fiscal year ended Dec 31, 2025), up 6.4% from $134.86M a year earlier. Net income was $6.63M, up 182.6% year over year, a net margin of 4.6%. Gross margin was 56.0% and operating margin 8.3%. In the most recent quarter, Q2 fiscal 2026 (ended Jun 30, 2026), revenue was $36.93M, up 2.6% from the same quarter a year earlier.

InfuSystem Holdings Income Statement Analysis

Values in millions USD

Scroll to see more
InfuSystem Holdings, Inc. income statement - Annual data in millions USD
BreakdownFY 2025FY 2024FY 2023FY 2022FY 2021FY 2020FY 2019FY 2018FY 2017
Period endingDec 2025Dec 2024Dec 2023Dec 2022Dec 2021Dec 2020Dec 2019Dec 2018Dec 2017
Revenue & Gross Profit
Revenue143.44134.86125.79109.91102.3896.6081.1267.1471.08
Cost of Revenue63.1464.4662.6849.3543.8538.6334.2328.1227.72
Gross Profit80.3070.4063.1160.5658.5457.9746.8839.0243.36
Operating Expenses
Research & Development0.000.000.000.000.000.000.000.000.00
Selling, General & Administrative67.4662.5258.0356.4151.4544.8638.9233.9534.98
Operating Expenses68.3863.5159.0258.9155.7249.1443.3638.6046.18
Operating Income11.926.894.091.652.828.833.530.42-3.81
Other Income/Expense
Interest Income0.000.000.000.000.000.000.000.000.00
Interest Expense1.301.78-2.17-1.401.38-1.261.901.421.33
Other Income/Expense0.00-0.06-2.24-1.52-1.56-0.03-2.00-1.46-1.45
Income
Income Before Tax10.625.061.850.131.267.541.52-1.04-5.26
Income Tax Expense4.002.710.980.11-0.16-9.790.160.0515.45
Net Income6.632.350.870.021.4217.331.36-1.10-20.71
Net Income - Continuous Operations6.632.350.870.021.4217.331.36-1.10-20.71
Net Income - Discontinued Operations---------
EBITDA25.2219.3416.5014.9117.2620.9515.7711.698.60
EBIT11.926.844.091.652.828.83---
Depreciation & Amortization0.920.9912.4113.2614.6312.1312.3411.3112.52
Earnings Per Share
Basic EPS-----1.00---1.00
Diluted EPS-----1.00---1.00
Basic Shares Outstanding20.6621.2721.0220.6520.5220.1119.7321.4222.74
Diluted Shares Outstanding21.1021.7121.6521.5522.0521.7220.8421.4222.74

Source: Company financial statements from annual and quarterly filings. Data as of Jun 30, 2026. Data sources and methodology

Frequently Asked Questions About InfuSystem Holdings Financial Statements

What was InfuSystem Holdings's revenue in fiscal 2025?

InfuSystem Holdings reported revenue of $143.44M in fiscal 2025 (fiscal year ended Dec 31, 2025). That was up 6.4% from $134.86M a year earlier.

Is InfuSystem Holdings profitable?

Yes. InfuSystem Holdings earned net income of $6.63M in fiscal 2025, a net margin of 4.6%. In fiscal 2024 it earned $2.35M.

What is InfuSystem Holdings's operating margin?

InfuSystem Holdings's operating income was $11.92M on revenue of $143.44M in fiscal 2025, an operating margin of 8.3%, compared with 5.1% a year earlier.

What is net profit margin?

Net profit margin is net income divided by revenue. It shows how much of each dollar of sales a company keeps as profit after all costs, interest and taxes. Full definition